Hologic HOLX
-
New Morningstar Analyst Report for Qiagen NV
… larger powerhouses like Roche RHHBY, Hologic HOLX , Gen-Probe GPRO, and others ..... more established foes like Roche, Hologic , and Gen-Probe within the diagnostic ..... molecular diagnostics space-- Hologic 's agreement to acquire Gen-Probe …
-
Hologic ([[ HOLX ]] +1.6%) ticks higher after JPMorgan ups the shares to Overweight. The firm says the upgrade was made to reflect compelling risk/reward and synergies from the Gen-Probe (GPRO) deal. ...
Hologic ( HOLX +1.6% ) ticks higher after JPMorgan ups the shares to Overweight. The firm says the upgrade was made to reflect compelling risk/reward and synergies from the Gen-Probe ( GPRO ) deal. Its price target is also raised to $22 from $20. Post your comment!
-
Trading Margins For Growth Isn't Going To Help Becton Dickinson
By Stephen Simpson : Becton Dickinson ( BDX ) has been a single-digit grower for most of the past decade, and that really hasn't seemed to bother anybody. There's nothing wrong with consistent high-quality performance, particularly when accompanied by improving free cash flow conversion. Although
-
Hologic Must Make The Third Time A Charm
… worse. That's the burden on Hologic ( HOLX ) now that it has announced a very ..... company Gen-Probe ( GPRO ). But as Hologic 's own second quarter earnings ..... the risk of burying the lede, Hologic 's fiscal second quarter earnings …
-
Hologic's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Hologic ( HOLX ) Q2 2012 Earnings Call April 30, 2012 8:15 am ET Executives Deborah R. Gordon - Vice President of Investor Relations Robert …
-
TEXT-S&P cuts Hologic rating to 'BB'
Overview -- Bedford, Mass.-based Hologic Inc. plans to acquire Gen-Probe Inc. for about $3.7 billion in cash. -- We are lowering our corporate credit and senior …
-
Hologic to buy Gen-Probe for $3.75 billion
(Reuters) - Medical device maker Hologic Inc is buying diagnostic test firm Gen-Probe Inc for $3.75 billion cash, gaining access to molecular diagnostics products used to screen for blood diseases and test transplant compatibility.
-
UPDATE 5- Hologic to buy Gen-Probe for $3.75 billion
* To pay $82.75 for each Gen-Probe share, a 20 pct premium
-
Hologic ( HOLX ) -9.8% following news it's to pay ~$3.7B for Gen-Probe (GPRO), which skies 18.%. While Piper Jaffray's Bill Quirk says that "strategically, this makes all the sense in the world," ...
Hologic ( HOLX ) -9.8% following news it's to pay ~$3.7B for Gen-Probe ( GPRO ), which skies 18.% . While Piper Jaffray's Bill …
-
Premarket gainers: [[BKS]] +92%. [[DMD]] +38%. [[SUN]] +21%. [[WCRX]] +20%. [[GPRO]] +20%. [[XOMA]] +9%. [[IOC]] +5%. [[MNKD]] +5%. [[PLX]] +4%. [[ARNA]] +4%. [[AMRN]] +3%.Losers: [[LDK]] -14%. ...
Premarket gainers: BKS +92% . DMD +38% . SUN +21% . WCRX +20% . GPRO +20% . XOMA +9% . IOC +5% . MNKD +5% . PLX +4% . ARNA +4% . AMRN +3% . Losers: LDK -14% . SOHU -8% . GNC -5% . HUM -5% . HOLX -4% . SINA -3% . Post your comment!